A lipidomic perspective on inflammatory macrophage eicosanoid signaling

Advances in Biological Regulation

Volumn 54, Issue 1, 2014, Pages 99-110

  Norris, Paul C ^a   Dennis, Edward A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ICOSANOID; LIPID;

ANIMAL; CHEMISTRY; HUMAN; IMMUNOLOGY; MACROPHAGE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; EICOSANOIDS; HUMANS; LIPIDS; MACROPHAGES; SIGNAL TRANSDUCTION;

EID: 84893396847     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2013.09.009     Document Type: Review

References (72)

1. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009, 27:669-692.
2. Biswas S.K., Gangi L., Paul S., Schioppa T., Saccani A., Sironi M., et al. Adistinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood 2006, 107:2112-2122.
3. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010, 11:889-896.
4. Bleau G., Massicotte F., Merlen Y., Boisvert C. Mammalian chitinase-like proteins. Exs 1999, 87:211-221.
5. Buczynski M.W., Dumlao D.S., Dennis E.A. Thematic review series: proteomics. An integrated omics analysis of eicosanoid biology. JLipid Res 2009, 50:1015-1038.
6. Bulanova E., Budagian V., Orinska Z., Koch-Nolte F., Haag F., Bulfone-Paus S. ATP induces P2X7 receptor-independent cytokine and chemokine expression through P2X1 and P2X3 receptors in murine mast cells. JLeukoc Biol 2009, 85:692-702.
7. Cailhier J.F., Partolina M., Vuthoori S., Wu S., Ko K., Watson S., et al. Conditional macrophage ablation demonstrates that resident macrophages initiate acute peritoneal inflammation. JImmunol 2005, 174:2336-2342.
8. Chang Z.L. Recent development of the mononuclear phagocyte system: in memory of Metchnikoff and Ehrlich on the 100th anniversary of the 1908 Nobel prize in physiology or medicine. Biol Cell/Under Auspices Eur Cell Biol Org 2009, 101:709-721.
9. Chen C.J., Kono H., Golenbock D., Reed G., Akira S., Rock K.L. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 2007, 13:851-856.
10. de Villiers W.J., Smart E.J. Macrophage scavenger receptors and foam cell formation. JLeukoc Biol 1999, 66:740-746.
11. Dennis E.A., Cao J., Hsu Y.H., Magrioti V., Kokotos G. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev 2011, 111:6130-6185.
12. Dumlao D.S., Buczynski M.W., Norris P.C., Harkewicz R., Dennis E.A. High-throughput lipidomic analysis of fatty acid derived eicosanoids and N-acylethanolamines. Biochim Biophys Acta 2011, 1811:724-736.
13. Edwards J.P., Zhang X., Frauwirth K.A., Mosser D.M. Biochemical and functional characterization of three activated macrophage populations. JLeukoc Biol 2006, 80:1298-1307.
14. Erwig L.P., Henson P.M. Immunological consequences of apoptotic cell phagocytosis. Am J Pathol 2007, 171:2-8.
15. Fraser I., Hughes D., Gordon S. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nat 1993, 364:343-346.
16. Fusetti F., von Moeller H., Houston D., Rozeboom H.J., Dijkstra B.W., Boot R.G., et al. Structure of human chitotriosidase. Implications for specific inhibitor design and function of mammalian chitinase-like lectins. JBiol Chem 2002, 277:25537-25544.
17. Gavala M.L., Pfeiffer Z.A., Bertics P.J. The nucleotide receptor P2RX7 mediates ATP-induced CREB activation in human and murine monocytic cells. JLeukoc Biol 2008, 84:1159-1171.
18. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Sci 2010, 330:841-845.
19. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
20. Gregus A.M., Doolen S., Dumlao D.S., Buczynski M.W., Takasusuki T., Fitzsimmons B.L., et al. Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors. Proc Natl Acad Sci U S A 2012, 109:6721-6726.
21. Gupta S., Maurya M.R., Stephens D.L., Dennis E.A., Subramaniam S. An integrated model of eicosanoid metabolism and signaling based on lipidomics flux analysis. Biophys J 2009, 96:4542-4551.
22. Harmon G.S., Dumlao D.S., Ng D.T., Barrett K.E., Dennis E.A., Dong H., et al. Pharmacological correction of a defect in PPAR-gamma signaling ameliorates disease severity in Cftr-deficient mice. Nat Med 2010, 16:313-318.
23. Heilbronn L.K., Campbell L.V. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des 2008, 14:1225-1230.
24. Hoeffel G., Wang Y., Greter M., See P., Teo P., Malleret B., et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. JExp Med 2012, 209:1167-1181.
25. Ishikawa T.O., Herschman H.R. Conditional knockout mouse for tissue-specific disruption of the cyclooxygenase-2 (Cox-2) gene. Genes 2006, 44:143-149.
26. Ishikawa T.O., Oshima M., Herschman H.R. Cox-2 deletion in myeloid and endothelial cells, but not in epithelial cells, exacerbates murine colitis. Carcinogens 2011, 32:417-426.
27. Jiang L.H. Inhibition of P2X(7) receptors by divalent cations: old action and new insight. EBJ 2009, 38:339-346.
28. Khakh B.S. Molecular physiology of P2X receptors and ATP signalling at synapses. Nat Rev Neurosci 2001, 2:165-174.
29. Klimp A.H., de Vries E.G., Scherphof G.L., Daemen T. Apotential role of macrophage activation in the treatment of cancer. Crit Rev Oncol Hematol 2002, 44:143-161.
30. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat Rev Immunol 2008, 8:279-289.
31. Kreider T., Anthony R.M., Urban J.F., Gause W.C. Alternatively activated macrophages in helminth infections. Curr Opin Immunol 2007, 19:448-453.
32. Kzhyshkowska J., Mamidi S., Gratchev A., Kremmer E., Schmuttermaier C., Krusell L., et al. Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood 2006, 107:3221-3228.
33. Lao H.C., Akunda J.K., Chun K.S., Flake G.P., Yuspa S.H., Langenbach R. Genetic ablation of cyclooxygenase-2 in keratinocytes produces a cell-autonomous defect in tumor formation. Carcinogens 2012, 33:2293-2300.
34. Li A.C., Glass C.K. The macrophage foam cell as a target for therapeutic intervention. Nat Med 2002, 8:1235-1242.
35. Lin E.Y., Li J.F., Gnatovskiy L., Deng Y., Zhu L., Grzesik D.A., et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 2006, 66:11238-11246.
36. Linton M.F., Fazio S. Class A scavenger receptors, macrophages, and atherosclerosis. Curr Opin Lipidol 2001, 12:489-495.
37. Lucas T., Waisman A., Ranjan R., Roes J., Krieg T., Muller W., et al. Differential roles of macrophages in diverse phases of skin repair. JImmunol 2010, 184:3964-3977.
38. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002, 23:549-555.
39. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front Biosci 2008, 13:453-461.
40. Mellor A.L., Munn D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004, 4:762-774.
41. Miller C.M., Boulter N.R., Fuller S.J., Zakrzewski A.M., Lees M.P., Saunders B.M., et al. The role of the P2X(7) receptor in infectious diseases. PLoS Pathog 2011, 7:e1002212.
42. Mirza R., DiPietro L.A., Koh T.J. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol 2009, 175:2454-2462.
43. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969.
44. Murakami M., Kudo I. Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog Lipid Res 2004, 43:3-35.
45. Norris P.C., Dennis E.A. Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling. Proc Natl Acad Sci U S A 2012, 109:8517-8522.
46. Norris P.C., Reichart D., Dumlao D.S., Glass C.K., Dennis E.A. Specificity of eicosanoid production depends on the TLR-4-stimulated macrophage phenotype. JLeukoc Biol 2011, 90:563-574.
47. O'Shea J.J., Murray P.J. Cytokine signaling modules in inflammatory responses. Immunity 2008, 28:477-487.
48. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010, 72:219-246.
49. Ottaviani E., Franceschi C. The invertebrate phagocytic immunocyte: clues to a common evolution of immune and neuroendocrine systems. Immunol Today 1997, 18:169-174.
50. Park J.S., Svetkauskaite D., He Q., Kim J.Y., Strassheim D., Ishizaka A., et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. JBiol Chem 2004, 279:7370-7377.
51. Pollard J.W. Macrophages define the invasive microenvironment in breast cancer. JLeukoc Biol 2008, 84:623-630.
52. Quehenberger O., Armando A., Dumlao D., Stephens D.L., Dennis E.A. Lipidomics analysis of essential fatty acids in macrophages. Prostaglandins, Leukot Essent Fatty Acids 2008, 79:123-129.
53. Raes G., De Baetselier P., Noel W., Beschin A., Brombacher F., Hassanzadeh Gh G. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. JLeukoc Biol 2002, 71:597-602.
54. Rosen H., Gordon S. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells invitro and inflammatory cell recruitment invivo. JExp Med 1987, 166:1685-1701.
55. Sabido E., Quehenberger O., Shen Q., Chang C.Y., Shah I., Armando A.M., et al. Targeted proteomics of the eicosanoid biosynthetic pathway completes an integrated genomics-proteomics-metabolomics picture of cellular metabolism. MCP 2012, 11. M111 014746.
56. Schulz C., Gomez Perdiguero E., Chorro L., Szabo-Rogers H., Cagnard N., Kierdorf K., et al. Alineage of myeloid cells independent of Myb and hematopoietic stem cells. Sci 2012, 336:86-90.
57. Serbina N.V., Jia T., Hohl T.M., Pamer E.G. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008, 26:421-452.
58. Shi C., Pamer E.G. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011, 11:762-774.
59. Shinomiya S., Naraba H., Ueno A., Utsunomiya I., Maruyama T., Ohuchida S., et al. Regulation of TNFalpha and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists. Biochem Pharmacol 2001, 61:1153-1160.
60. Sica A., Mantovani A. Macrophage plasticity and polarization: invivo veritas. JClinical Invest 2012, 122:787-795.
61. Siddiqui R., Khan N.A. Acanthamoeba is an evolutionary ancestor of macrophages: a myth or reality?. Exp Parasitol 2012, 130:95-97.
62. Smith J.D., Trogan E., Ginsberg M., Grigaux C., Tian J., Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A 1995, 92:8264-8268.
63. Stein M., Keshav S., Harris N., Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. JExp Med 1992, 176:287-292.
64. Stout R.D., Jiang C., Matta B., Tietzel I., Watkins S.K., Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. JImmunol 2005, 175:342-349.
65. Tam V.C., Quehenberger O., Oshansky C.M., Suen R., Armando A.M., Treuting P.M., et al. Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation. Cell 2013, 154:213-227.
66. Wada M., DeLong C.J., Hong Y.H., Rieke C.J., Song I., Sidhu R.S., et al. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. JBiol Chem 2007, 282:22254-22266.
67. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. JClin Invest 2003, 112:1796-1808.
68. Wood W., Turmaine M., Weber R., Camp V., Maki R.A., McKercher S.R., et al. Mesenchymal cells engulf and clear apoptotic footplate cells in macrophageless PU.1 null mouse embryos. Develop 2000, 127:5245-5252.
69. Wynn T.A., Chawla A., Pollard J.W. Macrophage biology in development, homeostasis and disease. Nat 2013, 496:445-455.
70. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. JClin Invest 2003, 112:1821-1830.
71. Yu X.H., Fu Y.C., Zhang D.W., Yin K., Tang C.K. Foam cells in atherosclerosis. Clin Chim Acta Int J Clin Chem 2013, 424:245-252.
72. Zhu Z., Zheng T., Homer R.J., Kim Y.K., Chen N.Y., Cohn L., et al. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Sci 2004, 304:1678-1682.